Discover
CUE
Cue Biopharma, Inc.
27.66
2 x 20.09
2 x 35.18
bid
ask
+
5.33
23.87%
2 @ 04:50 PM
28.13 +0.47 (1.70%)
| Ytd | 202.30% | |
| 1y | -0.43% |
22.10
day range
28.95
5.31
52 week range
37.84
| Open | 22.21 | Prev Close | 22.33 | Low | 22.10 | High | 28.95 | Mkt Cap | 200.93M |
| Vol | 394.67K | Avg Vol | 267.15K | EPS | -29.59 | P/E | N/A | Forward P/E | -1.79 |
| Beta | 1.80 | Short Ratio | 1.54 | Inst. Own | 23.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 28.12 | 200-d Avg | 20.35 | 1yr Est | 3.60 |
| Income Statement | |||
| Total Revenue | 7.88M | ||
| Revenues (USD) | 7.88M | ||
| Gross Profit | 7.88M | ||
| Operating Expenses | 95.57M | ||
| Research and Development Expense | 49.01M | ||
| Selling, General and Administrative Expense | 46.57M | ||
| Operating Income | -87.69M | ||
| Interest Expense | 5.00K | ||
| Net Income | -153.07M | ||
| Net Income Common Stock | -153.07M | ||
| Net Income Common Stock (USD) | -153.07M | ||
| Consolidated Income | -153.07M | ||
| Earnings per Basic Share | -24.14 | ||
| Earnings per Basic Share (USD) | -24.14 | ||
| Earnings per Diluted Share | -24.14 | ||
| Earning Before Interest & Taxes (EBIT) | -153.06M | ||
| Earning Before Interest & Taxes (USD) | -153.06M | ||
| Weighted Average Shares | 6.34M | ||
| Weighted Average Shares Diluted | 6.34M | ||
| Balance Sheet | |||
| Cash and Equivalents | 18.17M | ||
| Cash and Equivalents (USD) | 18.17M | ||
| Trade and Non-Trade Receivables | 5.38M | ||
| Current Assets | 26.62M | ||
| Property, Plant & Equipment Net | 3.21M | ||
| Total Assets | 30.71M | ||
| Debt Current | 1.63M | ||
| Total Debt | 3.08M | ||
| Current Liabilities | 21.22M | ||
| Debt Non-Current | 1.45M | ||
| Total Liabilities | 28.40M | ||
| Accumulated Retained Earnings (Deficit) | -526.71M | ||
| Shareholders Equity | 2.31M | ||
| Shareholders Equity (USD) | 2.31M | ||
| Assets Non-Current | 4.08M | ||
| Total Debt (USD) | 3.08M | ||
| Liabilities Non-Current | 7.18M | ||
| Trade and Non-Trade Payables | 4.71M | ||
| Tax Assets | 1.90M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 408.00K | ||
| Net Cash Flow from Financing | 30.02M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.01M | ||
| Issuance (Purchase) of Equity Shares | 30.02M | ||
| Net Cash Flow from Operations | -29.00M | ||
| Share Based Compensation | 23.84M | ||